Thymmune Therapeutics Alternatives & Competitors
12 companies similar to Thymmune Therapeutics — Biotech firm developing thymic cell therapies to restore immune function using m...
Companies similar to Thymmune Therapeutics
Fate Therapeutics Inc.
Transforming the lives of patients with autoimmune diseases and cancer.
San Diego, United States
RemedyBio
Remedy is creating a revolution in immune therapeutics though cell-by-cell analysis of imm...
Dublin, Ireland
Repertoire Immune Medicines
Repertoire is a biotechnology company creating a new category of immune medicines for canc...
Cambridge, United States
Longeveron Inc
Cell-Based Therapies
Miami, United States
Rival Readout
Competing with Thymmune Therapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Tessa Therapeutics Ltd
A clinical-stage biotech company developing autologous and allogeneic cell therapies for t...
Singapore, Singapore
Attovia Therapeutics
Creating medicines for immune-mediated disease using ATTOBODY®, a proprietary biologics pl...
San Carlos, United States
Rampart Bioscience
Leading a new era of effective, safe and accessible gene medicines.
Monrovia, United States
Asylia Therapeutics
Innovative therapies reshaping immune responses against autoimmune, cancer, and infectious...
-logo.jpg "Enlivex Therapeutics (Nasdaq: ENLV)"){kind=logo}
Enlivex Therapeutics (Nasdaq: ENLV)
Immune rebalancing
Israel
Q32 Bio Inc.
Revolutionizing the future of targeted immune therapeutics
Waltham, United States
Immunaeon
Connecting Today's Science to Tomorrow's Cures
Buffalo, United States
Georgiamune Inc.
Georgiamune is reprogramming immune signaling pathways to redirect the immune system to fi...
Gaithersburg, United Stat...
About Thymmune Therapeutics
Thymmune Therapeutics, a Cambridge, MA-based biotech firm, is pioneering in the realm of thymic cell therapies with an innovative use of machine learning to restore immune function. Founded in 2019, the company focuses on developing a unique platform that utilizes iPSC-thymic cell manufacturing to produce scalable, off...
Development of thymic cell engineering platform, Mass production of iPSC-derived thymic cells, Research and development of therapies for immune disorders, Preclinical studies of thymic cell therapy, Therapeutic development for healthy immune aging
Patients with immune-mediated diseases, Individuals with immunodeficiencies, Patients experiencing age-related immune decline, Healthcare professionals seeking innovative treatments
Thymic Cell Therapies, IPSC Manufacturing, Immunotherapy, Immune Restoration, Aging, Disease Treatment, Immunodeficiencies, Transplant Therapeutics, Autoimmune Diseases, Cell Engineering, Off-the-shelf Therapies, Therapeutic Pipeline, Biotech Innovation
B2B, B2D, Platform
Product Sales, Licensing, Service Fee
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Thymmune Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Thymmune Therapeutics on 4 Mar 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 29 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
